Jasper Therapeutics, Inc. (JSPRW) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $28.69M | -59.9% |
| 2024 | $71.64M | -17.6% |
| 2023 | $86.89M | +127.2% |
| 2022 | $38.25M | -54.8% |
| 2021 | $84.70M | +327.0% |
| 2020 | $19.84M | +1535.8% |
| 2019 | $1.21M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $28.69M | -59.9% |
| 2024 | $71.64M | -17.6% |
| 2023 | $86.89M | +127.2% |
| 2022 | $38.25M | -54.8% |
| 2021 | $84.70M | +327.0% |
| 2020 | $19.84M | +1535.8% |
| 2019 | $1.21M | — |